WORLD X-RAY SCIENCE FACILITIES ARE CONTRIBUTING TO OVERCOMING COVID-19
The COVID-19 pandemic is, more than ever, uniting scientists and the X-ray
Science Facilities worldwide, in their sorrow for the loss of life and
the suffering the virus has caused for the people around the world. They
also express heartfelt admiration and lasting gratitude to all frontline
health workers for their tireless dedication to treating the people impacted
by the pandemic.
The international network of X-ray Science Facilities, composed of the X-ray Synchrotron Radiation and X-ray Free Electron Laser Facilities, is deeply engaged with overcoming the pandemic. The X- ray Science Facilities role is to create and implement scientific and technological research activities to effectively study, understand and contribute solutions to the COVID-19 pandemic, including new drugs, therapeutic strategies and medical equipment developments.
This engagement has already started worldwide, and many X-ray Science Facilities are carrying out research focused on the SARS-CoV-2 virus, and making available their instruments with rapid access and remote channels to scientists desiring to address specific COVID-19 research topics.
The X-ray Science Facilities gathered to align intents and strategies on “development of alliances between universities, industry and facilities” at their first SR9 Summit, which was held in Sendai, Japan in April 2019.
The X-ray Science Facilities, with the intent to further coordinate and strengthen their support of scientific research and solutions to the COVID-19 pandemic, assembled for a remote access video SR20 Summit on 23-24 April 2020. They shared their experience on facility activities in the recent weeks, and decided to develop a cooperative strategy across all facilities worldwide to work jointly to overcome the pandemic.
The X-ray Science Facilities adopted the following Action Plan:
1) Share information and contribute to the coordination of efforts across all X-ray Science Facilities on scientific research addressing the COVID-19 pandemic
2) Explore the establishment of a worldwide X-ray Science Facilities network including university and industrial users for a comprehensive mobilization of facilities
3) Study the development of a shared IT system to accelerate the process of information distribution, favor global cooperation among facilities, and enable the most rapid and effective access for scientific projects across facilities
4) Exchange experience on remote access and sample mail-in procedures by the user community to maintain and strengthen experimental activities without user travel.
5) Coordinate efforts of the X-ray Science Facilities with those of other analytical facilities as, for example, those using neutrons, cryo-electron-microscopy, lasers and nuclear magnetic resonance
Prof. Dr. Hideo Ohno, President, TOHOKU University
Dr. Chi-Chang Kao, Director, SLAC National Accelerator Laboratory
Prof. Paul McIntyre, Director, SSRL
Prof. Michael Dunne, Director, LCLS
Dr. Stephen Streiffer, Director, Advanced Photon Source
Dr. Stephen Kevan, Director, Advanced Light Source
Dr. John Hill, Director, NSLS-Il
Prof. Joel Brock, Director, CHESS
Prof. Andrew Peele, Director, ANSTO Australian Synchrotron
Dr. Gwo-Hui Luo, Director, NSRRC
Dr. Tetsuya Ishikawa Director, RIKEN SPring-8 Center
Dr. Tn Soo Ko, Director, Pohang Accelerator Laboratory
Dr. Francesco Sette, Director General, ESRF
Prof. Edgar Weckert, Research Director, DESY
Prof. Robert Feidenhans'l, Manag Director, European XFEL
Dr. Jean Daillant, Director, Soleil Laboratory
Dr. Andrew Harrison, CEO, Diamond Light Source Limited
Dr. Caterina Biscari, Director, ALBA
Prof. Gabriel Aeppli, Professor, Head Photon Science Division, Paul Scherrer Insitut, ETH and EPFL
Dr. Ian McNulty, Director, MAX-IV
Prof. Jan Luning, Scientific Director, BESSY II @ Helmholtz-Zentrum Berlin
Dr. Claudio Masciovecchio, Director, FERMI Free Electron Laser
Prof. Robert Lamb, CEO, Canadian Lightsource Inc.
Signatures were removed because of privacy protection.
Regarding next-generation synchrotron radiation use to promote suppression
research of COVID-19
Tohoku University has summarized the technologies related to synchrotron
radiation and then can promote researchers for various studies aimed at
controlling infectious diseases (COVID-19) by the new coronavirus (SARS-CoV-2)
as shown in the following list. These are based on consideration of development as a feasibility study (FS) with industry as part of the promotion of next-generation synchrotron radiation facility development. In either case, the use of synchrotron radiation makes it possible for research to perform extremely smooth and accurate measurements and evaluations.
Based on this list, it is possible to exchange information on major synchrotron radiation
facilities around the world and COVID-19 suppression related research,
and aim for more accurate and speedy research execution through mutual
exchange. Therefore, we decided to urgently hold the 2nd World Summit of
Synchrotron Radiation Facilities. At the plenary session, after exchanging
opinions on the individual research contents and utilization status of
synchrotron radiation facilities, we finally declared that the synchrotron
radiation facilities of the world will unite and confront this humanity's
Chair: Jerome Hastings (SLAC National Accelerator Laboratory)
1. Welcome address: Hideo Ohno (President of Tohoku University)
2. Introduction of delegates
3. Approve of Agenda: Jerome Hastings
4. Highlights: SR activities to contribute overcoming the COVID-19 pandemic
5. Action Plan to activities to contribute overcoming the COVID-19 pandemic
1) Entire range of emergency cooperation
2) Consolidate of SR network with universities & Industry
3) Foster and strengthen the tele-utilization scheme globally
6. Closing remarks: Atsushi Muramatsu (Director, International Center of Synchrotron Radiation Innovation Smart; SRIS)
For inquiries, please contact us via E-mail.
next3gev(at)grp.tohoku.ac.jp Replace (at) with @
SR technology contributing to research related to SARS-CoV-2 infectious
Synchrotron radiation technology for research related to SARS-CoV-2 (new coronavirus) infectious disease (COVID-19)
Based on this list, we would like to respond to requests from researchers
in companies and academic fields for using synchrotron radiation facilities
to solve various COVID-19 issues within the framework of Coalition. Therefore,
we are urgently recruiting research subjects related to these lists. Unlike
the conventional method of using synchrotron radiation facilities, the
framework of Coalition is specialized in cutting-edge practical research,
and since the selection of issues is the fastest, it usually takes six
months to one year instead of the shortest. Will be shortened to a few
days. For those who are involved in each research institution, please contact
us by e-mail for the details of application.
sris(at)grp.tohoku.ac.jp Replace (at) with @
Feasibility Study (FS)
The Feasibility Study (FS) is an existing overseas synchrotron radiation system to embody the "coalition concept" proposed by industry and academia as a mechanism for operating synchrotron radiation facilities from advanced utilization to infrastructure utilization. The facility is being used in a wide range of fields, including biotechnology, nanotechnology, and food tech. This coalition concept was first proposed in Japan by the Photon Science Innovation Center in order to realize the next-generation synchrotron radiation facility that is being constructed on our campus. To date, more than 75 companies have announced their participation in the Coalition Concept, and more than 36 of them have participated in FS and are considering the utilization of next-generation synchrotron radiation facilities.
World Summit of Synchrotron Radiation Facility
The predecessor "Next Generation Synchrotron Radiation Summit" was held in Sendai City on April 21, last year, hosted by Tohoku University, where the world's synchrotron radiation facilities met together for the first time. At the conference, "We will establish a global summit conference that will be held as a regular forum to promote collaboration between universities, industry and facilities in order to promote the use of basic and applied research using synchrotron radiation. As a result of the adoption of the Aoba Communique, the agreement was reached for synchrotron radiation facilities around the world to hold this plenary session hosted by Tohoku University.
(1) Please tell us the purpose of holding the summit at this timing.
Since countermeasures against infectious diseases became an urgent issue, synchrotron radiation facilities around the world have begun to focus on research related to solving the COVID-19 issue one after another.
There are more than 10 such facilities worldwide in Europe, Asia and the United States.
For example, it is used for structural analysis of proteins necessary for drug discovery and antibody development, and for material development of medical devices.
In Japan, SPring-8 has started similar efforts.
However, each synchrotron radiation facility is currently working on its own.
In the Next Generation Synchrotron Radiation Program, Tohoku University, which is a member of the regional partner, is in charge of academic support for Coalition.
As part of the promotion of the Next Generation Synchrotron Radiation Program, we would like to contribute to the activities of SPring-8 and other synchrotron radiation facilities by supporting the synchrotron radiation research related to COVID-19, which is a Correlation member. .
Fortunately, we have signed partnership agreements with 10 overseas synchrotron radiation facilities since last year's SUMMIT conference, and we are ready to collaborate with overseas facilities.
This time, we proposed to hold the second summit meeting as a place to call on these facilities and discuss cooperation between the facilities, and we received approval from nearly 20 facilities around the world.
We would like to make it possible for facilities to resolve this global urgent issue quickly by providing efficient international cooperation through the division of roles.
I hope that Tohoku University's activities in the development plan of the next-generation synchrotron radiation facility can contribute to that.
(2) I heard that it was sponsored by Tohoku University. Please tell us
who the researchers who will manage the meeting will be.
Atsushi MURAMATSU, Director, International Center for Synchrotron Radiation Innovation Smart, Tohoku University
(3) Who are the potential attendees in the US and France, and what will
they be like?
Plans are for the United States, France, Sweden, Germany, United Kingdom, Taiwan, Australia, South Korea, Switzerland, Italy and Spain.
(4) Please tell us how you are going to utilize the results of this conference for corona countermeasures, including future development of the conference.
At the conference, many synchrotron radiation facilities will be discussed
on how to coordinate international R & D competition in order to confront
the global crisis and coordinate their results effectively. Some have argued
that similar research could reduce wasteful competition and shorten R &
D time. Therefore, it may be possible to standardize a remote experiment
in which facilities around the world can be used in Japan by utilizing
an international information network, and conversely, facilities outside
Japan can use Japanese facilities. Let's We hope that by utilizing the
strengths of each facility and compensating for their weaknesses, we will
concentrate the strengths of facilities around the world and speed up R
& D to resolve coronavirus infectious diseases. Tohoku University,
which is a university, will serve as a host for facilitating discussions
at the summit, and we hope that this kind of facility cooperation will
lead to even more concrete implementation.
(5) There was also a presentation to the effect that “Recruit related research projects”. Although there was a notation such as accepting applications, please let me confirm whether it is a story related to the emergency meeting or whether this "recruitment" is a story that Tohoku University will take the initiative.
The recruitment will be conducted as part of matching the coalitions of the regional partners of the Next Generation Synchrotron Radiation Program. The center of Tohoku University will take the initiative. In addition, if the Summit will be able to be implemented at overseas facilities such as Soleil in France where Tohoku University connects the borders, SLAC in the United States, and MAX-IV in Sweden, the next-generation synchrotron radiation plan will be urgent. I think that it has helped a little to take a step forward in the international collaboration of the facilities of the time.